Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

Inclusion Criteria: * Diagnosed with bacterial conjunctivitis in 1 or both eyes; * Able to understand and sign an informed consent form. If subject is \<18 years of age, the informed consent must be understood and signed by the subject's legally authorized representative; * Agrees to comply with the visit schedule and other requirements of the study; * Other protocol-specified inclusion criteria may apply. Exclusion Criteria: * Signs and symptoms of bacterial conjunctivitis for longer than 4 days prior to Day 1; * Presence of concomitant viral infection; * Infants with ophthalmia neonatorum of gonococcal, Chlamydia, herpetic or chemical origin; * Infants whose birth mothers had any sexually transmitted disease within 1 month prior to delivery; * Infants undergoing treatment for retinopathy of prematurity; * Contact lens wear during the course of the study; * Only 1 sighted eye or vision in either eye not correctable to 0.6 logMAR units (20/80) or better; * Use of medications, as specified in the protocol; * Any systemic or ocular disease or disorder, complicating factors or structural abnormality that could negatively affect the conduct or outcome of the study; * Known or suspected allergy or hypersensitivity to fluoroquinolones; * Pregnant, lactating, or of childbearing potential and not using adequate birth control to prevent pregnancy; * Other protocol-specified exclusion criteria may apply.